Back

Short and medium chain acylcarnitines as markers of outcome in diabetic and non-diabetic subjects with acute coronary syndromes

28 August 2020 (08:00 - 18:00)
Organised by:
Congress Presentation Part of: Acute Coronary Syndromes ePosters Inflammation ESC Premium Access ESC Congress 2020

About the speaker

Photo
Doctor Allan Davies

John Hunter Hospital, Newcastle (Australia)

238 More presentations in this session

Presentation thumbnail
Prevalence of thrombophilia and antiphospholipid syndrome in myocardial infarction with non-obstructive coronary arteries and cryptogenic stroke
Miss S. Kruchinova (Krasnodar, RU)
Abstract Slides
Presentation thumbnail
Impact of admission serum acid uric levels on in-hospital outcomes in patients with acute coronary syndrome
Doctor M. Centola (Desio, IT)
Abstract Slides
Presentation thumbnail
Clinical predictors and angiographic features of acute coronary syndromes caused by systemic embolism
Mr A. Jeronimo (Madrid, ES)
Abstract Slides
Presentation thumbnail
Morphological characteristics of plaque erosion with noncritical coronary stenosis: an optical coherence tomography study
Doctor C. Fang (Harbin, CN)
Abstract Slides
Presentation thumbnail
Metformin exerts cardioprotection via attenuating mitochondrial fission in cardiac ischaemia-reperfusion injury in rats
Doctor T. Clements (Chiang Mai, TH)
Abstract Slides

Access the full session

Session thumbnail
Acute Coronary Syndromes ePosters

The Event

Event poster

ESC Congress 2020

28 August 2020 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Plasma trimethylamine-N-oxide is an independent predictor of long-term cardiovascular mortality in patients undergoing percutaneous coronary intervention for acute coronary syndrome
29 June 2021
thumbnail
Congress Presentation
Cardiac intramyocellular lipid profile in type 2 diabetes
30 August 2025
thumbnail
Congress Presentation
Statin users have lower fatty acid oxidative metabolisms in muscle mitochondria and have a higher content of long-chain and medium-chain acylcarnitines in muscles.
29 August 2025
thumbnail
Webinar
Diabetes and ACS - enhancing post-discharge outcomes after primary PCI
26 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources